Abstract
Objective: To evaluate the long term (4 years) efficacy of deep brain stimulation (DBS) of the subthalamic nucleus (STN) in advanced Parkinson's disease.
Methods: We performed a double blind crossover evaluation of the efficacy of DBS of the STN in the "off" medication condition in 10 patients with Parkinson's disease. Assessments included the Unified Parkinson's Disease Rating Scale (UPDRS) part III (motor) and two timed tests (arm tapping and walking). Open evaluation of the effect of stimulation in the off and on drug states preoperatively and at 1 and 4 years postoperatively was also conducted. The latter assessment included the UPDRS parts II (activities of daily living) and III (dyskinesia scale and global assessment) as judged by the patient and examiner. The mean amount of levodopa daily dose at base line, 1 year, and 4 years after surgery was compared.
Results: A significant (p<0.04) effect of stimulation was observed in the overall group regarding both the UPDRS motor and the timed tests. Open evaluation also showed a significant benefit of STN DBS with respect to preoperative assessment in both the motor and activities of daily living scales, dyskinesia scale, and in global assessment. Levodopa daily dose was reduced by 48% and 50% at 1 and 4 years, respectively. There was no difference between the 1 and 4 years evaluations in any of the parameters evaluated. Complications due to stimulation were minor.
Conclusions: DBS of the STN provides a significant and persistent anti-parkinsonian effect in advanced Parkinson's disease 4 years after surgery.
Full Text
The Full Text of this article is available as a PDF (78.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Charles P. D., Van Blercom N., Krack P., Lee S. L., Xie J., Besson G., Benabid A-L, Pollak P. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology. 2002 Sep 24;59(6):932–934. doi: 10.1212/wnl.59.6.932. [DOI] [PubMed] [Google Scholar]
- Ghika J., Villemure J. G., Fankhauser H., Favre J., Assal G., Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg. 1998 Nov;89(5):713–718. doi: 10.3171/jns.1998.89.5.0713. [DOI] [PubMed] [Google Scholar]
- Houeto J. L., Mesnage V., Mallet L., Pillon B., Gargiulo M., du Moncel S. Tezenas, Bonnet A. M., Pidoux B., Dormont D., Cornu P. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):701–707. doi: 10.1136/jnnp.72.6.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T, Mizutani T. Double blinded evaluation of the effects of pallidal and subthalamic nucleus stimulation on daytime activity in advanced Parkinson's disease. Parkinsonism Relat Disord. 2000 Nov 1;7(1):35–40. doi: 10.1016/s1353-8020(00)00046-8. [DOI] [PubMed] [Google Scholar]
- Krack Paul, Batir Alina, Van Blercom Nadège, Chabardes Stephan, Fraix Valérie, Ardouin Claire, Koudsie Adnan, Limousin Patricia Dowsey, Benazzouz Abdelhamid, LeBas Jean François. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003 Nov 13;349(20):1925–1934. doi: 10.1056/NEJMoa035275. [DOI] [PubMed] [Google Scholar]
- Kuehler A., Henrich G., Schroeder U., Conrad B., Herschbach P., Ceballos-Baumann A. A novel quality of life instrument for deep brain stimulation in movement disorders. J Neurol Neurosurg Psychiatry. 2003 Aug;74(8):1023–1030. doi: 10.1136/jnnp.74.8.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar R., Lozano A. M., Kim Y. J., Hutchison W. D., Sime E., Halket E., Lang A. E. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology. 1998 Sep;51(3):850–855. doi: 10.1212/wnl.51.3.850. [DOI] [PubMed] [Google Scholar]
- Lagrange E., Krack P., Moro E., Ardouin C., Van Blercom N., Chabardes S., Benabid A. L., Pollak P. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology. 2002 Dec 24;59(12):1976–1978. doi: 10.1212/01.wnl.0000037486.82390.1c. [DOI] [PubMed] [Google Scholar]
- Lang Anthony E. Subthalamic stimulation for Parkinson's disease--living better electrically? N Engl J Med. 2003 Nov 13;349(20):1888–1891. doi: 10.1056/NEJMp038160. [DOI] [PubMed] [Google Scholar]
- Langston J. W., Widner H., Goetz C. G., Brooks D., Fahn S., Freeman T., Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992;7(1):2–13. doi: 10.1002/mds.870070103. [DOI] [PubMed] [Google Scholar]
- Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., Benabid A. L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998 Oct 15;339(16):1105–1111. doi: 10.1056/NEJM199810153391603. [DOI] [PubMed] [Google Scholar]
- Linazasoro G. Subthalamic deep brain stimulation for advanced Parkinson's disease: all that glitters is not gold. J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):827–827. doi: 10.1136/jnnp.74.6.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McIntosh Emma, Gray Alastair, Aziz Tipu. Estimating the costs of surgical innovations: the case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease. Mov Disord. 2003 Sep;18(9):993–999. doi: 10.1002/mds.10481. [DOI] [PubMed] [Google Scholar]
- Pahwa Rajesh, Wilkinson Steven B., Overman John, Lyons Kelly E. Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up. J Neurosurg. 2003 Jul;99(1):71–77. doi: 10.3171/jns.2003.99.1.0071. [DOI] [PubMed] [Google Scholar]
- Romito L. M. A., Scerrati M., Contarino M. F., Bentivoglio A. R., Tonali P., Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology. 2002 May 28;58(10):1546–1550. doi: 10.1212/wnl.58.10.1546. [DOI] [PubMed] [Google Scholar]
- Straits-Tröster K., Fields J. A., Wilkinson S. B., Pahwa R., Lyons K. E., Koller W. C., Tröster A. I. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation. Brain Cogn. 2000 Apr;42(3):399–416. doi: 10.1006/brcg.1999.1112. [DOI] [PubMed] [Google Scholar]
- Temperli P., Ghika J., Villemure J-G, Burkhard P. R., Bogousslavsky J., Vingerhoets F. J. G. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology. 2003 Jan 14;60(1):78–81. doi: 10.1212/wnl.60.1.78. [DOI] [PubMed] [Google Scholar]
- Umemura Atsushi, Jaggi Jurg L., Hurtig Howard I., Siderowf Andrew D., Colcher Amy, Stern Matthew B., Baltuch Gordon H. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg. 2003 Apr;98(4):779–784. doi: 10.3171/jns.2003.98.4.0779. [DOI] [PubMed] [Google Scholar]
- Vingerhoets François J. G., Villemure J-G, Temperli P., Pollo C., Pralong E., Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology. 2002 Feb 12;58(3):396–401. doi: 10.1212/wnl.58.3.396. [DOI] [PubMed] [Google Scholar]
- Volkmann J., Sturm V., Weiss P., Kappler J., Voges J., Koulousakis A., Lehrke R., Hefter H., Freund H. J. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Ann Neurol. 1998 Dec;44(6):953–961. doi: 10.1002/ana.410440615. [DOI] [PubMed] [Google Scholar]